HedgeChatter

  • Home /
  • Tag Archives

sarepta

Pipeline Updates Make These Three Biotech Stocks … – Benzinga

Related ICPTCNBC’s Meg Tirrel Speculates About Gilead’s New AcquisitonHow Wedbush’s Liana Moussatos Is Trading These Biopharma StocksShaken, Not Stirred: Is The ‘Biotech Bubble’ Beginning To Burst?(Seeking Alpha)Related Sarepta Therapeutics Announces New England Journal of Medicine Publication of Phase I Clinical Data of Marburg Drug Candidate, AVI-7288, Supporting Safety of the PMOplus® platformShort-Sellers Betting Against These BiotechsSarepta Posts Narrower-than-Expected Loss in […]

August 10, 2015 ByTipRanks , , , , , , , , , Comments Off on Pipeline Updates Make These Three Biotech Stocks … – Benzinga read more

Five Biotech Stocks for the Next Six Months – Stocks to Watch …

By Ben LevisohnSunTrust Robinson Humphrey’s Edward Nash and team offer five biotech stocks for the next six months:
Cempra (CEMP) ($50 PT), our top pick based on near-term clinical and commercial success potential. We recently met with management and it was reiterated that the second Phase III study of solithromycin in CABP (SOLITAIRE-IV) remains on track to report top-line data by […]

June 17, 2015 ByBen Levisohn , , , , , , , Comments Off on Five Biotech Stocks for the Next Six Months – Stocks to Watch … read more

Biotech Stock News (SRPT) (BMRN) (PBMD) (ISR) | CNA Finance

Sarepta Therapeutics (NASDAQ:SRPT)After the closing bell on May 19, 2015 shares of Sarepta Therapeutics were up as much as 38% in after-hours trading after the company reported that the FDA will allow the company to file a New Drug Application — NDA — for Eteplirsen. This drug Eteplirsen helps patients with Duchenne Muscular Dystrophy — DMD —  to restore dystrophin […]

May 26, 2015 ByTerry Chrisomalis , , , , , , , , , Comments Off on Biotech Stock News (SRPT) (BMRN) (PBMD) (ISR) | CNA Finance read more

Top 5 Biotech Stocks That The Smart Money Doesn't Like

View gallery.Preface: The biotech stocks considered for this review were confined to those over $10 per share that traded at least 500K shares a day based on a 90-day average.For the longest time it seemed that for every new high the S&P 500 hit, biotech stocks, as measured by the iShares Nasdaq Biotechnology Index (NASDAQ: IBB), hit two new […]

February 17, 2015 , , , , , , , Comments Off on Top 5 Biotech Stocks That The Smart Money Doesn't Like read more

Twitter's Favorite Biotech and Pharma Stocks

Mark Schoenebaum, the biotech and pharmaceutical analyst at Evercore ISI, asked ;the Twittersphere for their favorite drug stocks going into next year.
What’s your favorite stock for 2015 in biotech or Pharma?
– Mark Schoenebaum (@MarkSchoenebaum) December 12, 2014What was the top pick? A 21-way tie for first place. All 21 companies got a single vote.I kid you not. As I’m writing […]

December 16, 2014 , , , , , , , , , Comments Off on Twitter's Favorite Biotech and Pharma Stocks read more

Does George Soros Think Biotech's Bull Run Is Finally Coming to an End?

To say that biotech stocks have performed well as a group over the last two years is an understatement; they have absolutely crushed the broader markets. For example, the iShares Nasdaq Biotech Index has more than tripled the performance of the S&P 500 , and more than doubled the NASDAQ Composite , since 2012.This sustained move upward, though, has repeatedly […]

December 15, 2014 , , , , , , , , , Comments Off on Does George Soros Think Biotech's Bull Run Is Finally Coming to an End? read more

Sarepta Gets Delayed And The Stock Gets Drilled

View gallery.Biotech stocks can provide enormous gains, but unfortunately, they can take them away just as quickly.All it takes is one FDA approval for a biotech company’s stock to soar, but an FDA setback could also cause that same stock to tank. One biotech stock suffered that outcome Monday morning.Sarepta Therapeutics Inc (NASDAQ: SRPT) provided an update on its discussions […]

October 27, 2014 ByHedgeChatter , , , , , , , , Comments Off on Sarepta Gets Delayed And The Stock Gets Drilled read more